Handbook of Obesity - Volume 2

Clinical Applications
Herausgeber: Bouchard, Claude; Bray, George A.

• Gebundenes Buch

Produktbeschreibung

Volume 2 of the 5th Edition of the Handbook of Obesity spotlights on clinical applications for evaluation, diagnosis, prevention, and treatment of obesity. It covers on the several major developments occurred between the previous and the new edition.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis Ltd
• 5 ed
• Seitenzahl: 518
• Erscheinungstermin: 1. Dezember 2023
• Englisch
• Abmessung: 287mm x 218mm x 69mm
• Gewicht: 1616g
• ISBN-13: 9781032551081
• ISBN-10: 1032551089
• Artikelnr.: 68474154

Autorenporträt

George A. Bray, MD, MACP, MACE, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States Claude Bouchard, PhD, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States Peter T. Katzmarzyk, PhD, FACSM, FTOS, FAHA, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States John P. Kirwan, PhD, Integrated Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States Leanne M. Redman, PhD, Reproductive Endocrinology and Women's Health Laboratory, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, United States Philip R. Schauer, MD, Metamor Institute, Pennington Biomedical Research Center, Baton Rouge, Louisiana

Inhaltsangabe

Preface. About the Editors. Associate Editors. Contributors. Introduction
to Volume 2. PREVENTION AND ECONOMIC OUTCOMES OF OBESITY. Dietary Changes
in Human Evolution: Implications for the Prevention of Obesity.
Evolutionary Changes in Physical Activity, Diet, and Energy Expenditure:
Implications for the Prevention of Obesity. Prevention of Obesity in
Adults. The Prevention of Obesity in Children and Adolescents.
Re-engineering the Built Environment: Progress in Schools, Worksites,
Neighborhoods, and Communities. The Economic Costs of Obesity.
Cost-Effectiveness of Obesity Prevention and Treatment. Role of Government
and Non-government Organizations in the Obesity Pandemic and Its
Prevention. Role of Reimbursement in the Delivery of Treatment for Obesity
in Adults and Children. EVALUATION OF THE PATIENTS WITH OVERWEIGHT OR
OBESITY. Classification, Evaluation, and Staging of the Patient with
Obesity. Indicators of Central Adiposity: A Critical Evaluation of Their
Usefulness. Genetic Obesity Syndromes. Ethnic and Racial Considerations in
the Evaluation of the Patient with Obesity. LIFESTYLE IN THE MANAGEMENT OF
OBESITY: BEHAVIORAL MODIFICATION, DIET, AND EXERCISE. Best Practices:
Obesity and the Primary Care Providers. In-Person Behavioral Approaches for
Weight Management. Behavioral Interventions Delivered Remotely. Cultural
Considerations in Behavioral Therapy for the Management of Obesity. Diet
Composition and Weight Loss: Is a Calorie a Calorie? Circadian Rhythms and
Weight Loss: Timed Food Intake. Comparison of Modern-Millennial Diets.
Dietary Energy Density and Its Contribution to Weight Control. Dietary
Patterns as a Basis for Diet Selection. Physical Activity and Weight Loss:
Volume, Intensity, and Mode. Modifying Sedentary Behavior for the
Prevention and Treatment of Obesity. Preventing Weight Regain after Weight
Loss. Personalized and Precision Nutrition in the Management of Obesity:
Can We Tailor the Treatment to the Patient? MEDICATIONS IN THE MANAGEMENT
OF OBESITY. Drug-Associated Weight Gain and Clinical Alternatives.
Mechanisms of Drug Action in Obesity. Metabolic Effects of Progressive
Weight Loss. Older Drugs Used to Manage Obesity: Sympathomimetics and
Orlistat. Serotonergic Drugs for Treating Obesity. Antidiabetic Drugs That
Reduce Weight and Are Cardioprotective. Approved Combination Agents:
Phentermine/Topiramate. Approved Combination Agents: Naltrexone-Bupropion.
Drugs That Affect Body Weight: The Glucagon-Like Peptide-1. Agonists.
Hydrogels in the Treatment of Obesity. Dual and Triple-Action Peptides.
Antiobesity Medications on the Horizon. Treatments for Rare Forms of
Genetic Obesity. Special Issues in Using Medications in Children and
Adolescents. Dietary Supplements and Weight Management. SURGICAL
INTERVENTIONS FOR OBESITY. Historical Overview of Metabolic and Bariatric
Surgery. Overview: Current Metabolic Operations and Long-Term Outcomes.
Effects of Metabolic Surgery on Type 2. Diabetes. Cardiovascular Outcomes
in Metabolic Surgery. Effect of Bariatric Surgery on Cancer. Bariatric
Surgery in Pediatric Patients. Other Bariatric Procedures: Nerve
Stimulation, Gastric Balloons, Intestinal Liners, and Others. Index.